[{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB04-02 Biomarkers of metastasis,,"},{"Key":"Keywords","Value":"Metastasis,Adenocarcinoma,Colorectal cancer,Methylation abnormality,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"K. Saskova<sup>1<\/sup>, M. Landfors<sup>2<\/sup>, J. Horak<sup>1<\/sup>, K. Honkova<sup>1<\/sup>, K. Tomasova<sup>1<\/sup>, J. Drabova<sup>3<\/sup>, F. S. Hackenhaar<sup>2<\/sup>, J. Pavlikova<sup>1<\/sup>, L. Vodickova<sup>1<\/sup>, T. Nilsson<sup>2<\/sup>, S. Farkas<sup>4<\/sup>, V. Vymetalkova<sup>1<\/sup>, P. Vodicka<sup>1<\/sup>, S. Degerman<sup>2<\/sup>, <b>M. Kroupa<\/b><sup>1<\/sup>; <br\/><sup>1<\/sup>Institute of Experimental Medicine of the CAS, Prague, Czech Republic, <sup>2<\/sup>Umeå University, Umeå, Sweden, <sup>3<\/sup>University Hospital Motol, Prague, Czech Republic, <sup>4<\/sup>Örebro University, Örebro, Sweden","CSlideId":"","ControlKey":"94eb3aa5-d0a7-4d06-9ae6-48bb6d246738","ControlNumber":"10354","DisclosureBlock":"&nbsp;<b>K. Saskova, <\/b> None..<br><b>M. Landfors, <\/b> None..<br><b>J. Horak, <\/b> None..<br><b>K. Honkova, <\/b> None..<br><b>K. Tomasova, <\/b> None..<br><b>J. Drabova, <\/b> None..<br><b>F. S. Hackenhaar, <\/b> None..<br><b>J. Pavlikova, <\/b> None..<br><b>L. Vodickova, <\/b> None..<br><b>T. Nilsson, <\/b> None..<br><b>S. Farkas, <\/b> None..<br><b>V. Vymetalkova, <\/b> None..<br><b>P. Vodicka, <\/b> None..<br><b>S. Degerman, <\/b> None..<br><b>M. Kroupa, <\/b> None.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10695","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"1","PosterboardNumber":"1","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB206","PresenterBiography":null,"PresenterDisplayName":"Michal Kroupa, PhD","PresenterKey":"94692e2b-cf78-4d14-aed2-678912959a6c","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB206. <b>The progression of chromosomal instability and aberrant DNA methylation during colorectal cancer development<\/b>","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"<b>The progression of chromosomal instability and aberrant DNA methylation during colorectal cancer development<\/b>","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB04-02 Biomarkers of metastasis,,"},{"Key":"Keywords","Value":"Squamous cell carcinoma,Skin,Metastasis,Biomarkers,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"L. Heiskanen<sup>1<\/sup>, L. Nissinen<sup>1<\/sup>, E. Siljamäki<sup>1<\/sup>, J. Knuutila<sup>1<\/sup>, T. Pellinen<sup>2<\/sup>, M. Kallajoki<sup>3<\/sup>, J. Heino<sup>1<\/sup>, P. Riihilä<sup>1<\/sup>, <b>V.-M. Kähäri<\/b><sup>1<\/sup>; <br\/><sup>1<\/sup>University of Turku, Turku, Finland, <sup>2<\/sup>University of Helsinki, Helsinki, Finland, <sup>3<\/sup>Turku University Hospital, Turku, Finland","CSlideId":"","ControlKey":"379ad468-9166-46ce-91a9-e5d929ff5506","ControlNumber":"10752","DisclosureBlock":"&nbsp;<b>L. Heiskanen, <\/b> None..<br><b>L. Nissinen, <\/b> None..<br><b>E. Siljamäki, <\/b> None..<br><b>J. Knuutila, <\/b> None..<br><b>T. Pellinen, <\/b> None..<br><b>M. Kallajoki, <\/b> None..<br><b>J. Heino, <\/b> None..<br><b>P. Riihilä, <\/b> None..<br><b>V. Kähäri, <\/b> None.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10696","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"2","PosterboardNumber":"2","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB207","PresenterBiography":"","PresenterDisplayName":"Veli-Matti Kähäri, MD;PhD","PresenterKey":"f5787163-75fe-4f86-9b09-379a784e53f8","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB207. C5ar1 is a novel biomarker and potential therapeutic target in advanced cutaneous squamous cell carcinoma","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"C5ar1 is a novel biomarker and potential therapeutic target in advanced cutaneous squamous cell carcinoma","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB04-03 Epithelial\/mesenchymal transition (EMT and MET),,"},{"Key":"Keywords","Value":"Epithelial-mesenchymal transition (EMT),Wnt signaling,ERK,Transcription factor,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>H. Liang<\/b><sup>1<\/sup>, O. Benard<sup>1<\/sup>, Z. Ren<sup>1<\/sup>, K. Suyama<sup>1<\/sup>, J. Wang<sup>1<\/sup>, A. Griffen<sup>1<\/sup>, H. Wang<sup>1<\/sup>, L. LeFave<sup>1<\/sup>, L. Norton<sup>2<\/sup>, R. B. Hazan<sup>1<\/sup>; <br\/><sup>1<\/sup>Albert Einstein College of Medicine, BRONX, NY, <sup>2<\/sup>Memorial Sloan Kettering Cancer Center, New York, NY","CSlideId":"","ControlKey":"75cca646-5c2b-41dd-8ebb-52afee9ad89f","ControlNumber":"10436","DisclosureBlock":"&nbsp;<b>H. Liang, <\/b> None..<br><b>O. Benard, <\/b> None..<br><b>Z. Ren, <\/b> None..<br><b>K. Suyama, <\/b> None..<br><b>J. Wang, <\/b> None..<br><b>A. Griffen, <\/b> None..<br><b>H. Wang, <\/b> None..<br><b>L. LeFave, <\/b> None..<br><b>L. Norton, <\/b> None..<br><b>R. B. Hazan, <\/b> None.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10697","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"3","PosterboardNumber":"3","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB208","PresenterBiography":null,"PresenterDisplayName":"Huizhi Liang, MS;PhD","PresenterKey":"29d48028-5a3b-49df-9da9-da39279bcb14","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB208. An intricate connection between canonical Wnt and MAPK\/ERK signaling drives the partial hybrid EMT state involving FOXC2\/p63 activation leading to cancer stemness and metastasis","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"An intricate connection between canonical Wnt and MAPK\/ERK signaling drives the partial hybrid EMT state involving FOXC2\/p63 activation leading to cancer stemness and metastasis","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB04-05 Genes that regulate migration and invasion,,"},{"Key":"Keywords","Value":"Cancer,Metastasis,RNA-binding protein,YBX1,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>S. Sol<\/b>, F. Boncimino, K. Todorova, A. Mandinova; <br\/>MGH\/Harvard Medical School, Boston, MA","CSlideId":"","ControlKey":"51fbf335-4dda-40eb-b6c1-0d26b59f6cae","ControlNumber":"9891","DisclosureBlock":"&nbsp;<b>S. Sol, <\/b> None..<br><b>F. Boncimino, <\/b> None..<br><b>K. Todorova, <\/b> None..<br><b>A. Mandinova, <\/b> None.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10698","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"4","PosterboardNumber":"4","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB209","PresenterBiography":null,"PresenterDisplayName":"Stefano Sol, PhD,BS,MS","PresenterKey":"b720f22d-7a82-4646-9900-d506fc665027","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB209. YBX1 is a negative regulator of post-transcriptional program associated to EMT, invasion and metastasis in cSCC","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"YBX1 is a negative regulator of post-transcriptional program associated to EMT, invasion and metastasis in cSCC","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB04-05 Genes that regulate migration and invasion,,"},{"Key":"Keywords","Value":"Polyamines,Histone deacetylase,Migration,HDAC inhibitor,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>T.-A. Liu<\/b><sup>1<\/sup>, A. Nwafor<sup>2<\/sup>, R. Kumar<sup>2<\/sup>, L. Sena<sup>2<\/sup>, R. R. Steimbach<sup>3<\/sup>, A. K. Miller<sup>3<\/sup>, R. A. Casero, Jr.<sup>2<\/sup>, T. M. Stewart<sup>2<\/sup>; <br\/><sup>1<\/sup>Johns Hopkins School of Public Health, Baltimore, MD, <sup>2<\/sup>Johns Hopkins University School of Medicine, Baltimore, MD, <sup>3<\/sup>German Cancer Research Center (DKFZ), Heidelberg, Germany","CSlideId":"","ControlKey":"8dac4492-2968-4675-97bc-c788e5a36052","ControlNumber":"10320","DisclosureBlock":"&nbsp;<b>T. Liu, <\/b> None..<br><b>A. Nwafor, <\/b> None..<br><b>R. Kumar, <\/b> None.&nbsp;<br><b>L. Sena, <\/b> <br><b>Panbela Therapeutics, Inc.<\/b> Grant\/Contract.<br><b>R. R. Steimbach, <\/b> None..<br><b>A. K. Miller, <\/b> None.&nbsp;<br><b>R. A. Casero, <\/b> <br><b>Panbela Therapeutics, Inc.<\/b> Grant\/Contract. <br><b>USWorldMeds<\/b> Grant\/Contract. <br><b>T. M. Stewart, <\/b> <br><b>Panbela Therapeutics, Inc.<\/b> Grant\/Contract.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10699","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"5","PosterboardNumber":"5","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB210","PresenterBiography":null,"PresenterDisplayName":"Ting-Ann Liu, BS","PresenterKey":"74cb4233-5332-419a-8aaf-44dadfc3adb6","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB210. Identification of histone deacetylase 10 as a repressor of cancer cell migration","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Identification of histone deacetylase 10 as a repressor of cancer cell migration","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB04-07 Invasion and migration,,"},{"Key":"Keywords","Value":"Head and neck squamous cell carcinoma,Metastasis,Cancer genomics,CRISPR\/Cas9,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>G. Flores<\/b>, S. Uaroon, M. Buchakjian; <br\/>Univ. of Iowa Hospitals and Clinics, Iowa City, IA","CSlideId":"","ControlKey":"dbfff063-fc98-492e-b0a9-272815e93b8b","ControlNumber":"9942","DisclosureBlock":"&nbsp;<b>G. Flores, <\/b> None..<br><b>S. Uaroon, <\/b> None..<br><b>M. Buchakjian, <\/b> None.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10700","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"6","PosterboardNumber":"6","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB211","PresenterBiography":null,"PresenterDisplayName":"Guillermo Flores, MD;PhD","PresenterKey":"b2a8ea66-d66f-4444-8ad7-a4aa99339334","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB211. Genetic complexity in OSCC metastasis: From transcription factors to novel therapeutic targets","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Genetic complexity in OSCC metastasis: From transcription factors to novel therapeutic targets","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB04-08 Metastasis-promoting genes,,"},{"Key":"Keywords","Value":"KRAS,Lung adenocarcinoma,Metastasis,Oncogene,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"M. Serresi, S. Kertalli, Y. Dramaretska, M. J. Schmitt, H. Naumann, M. Zschummel, <b>G. Gargiulo<\/b>; <br\/>Max Delbrück Center for Molecular Medicine, Berlin, Germany","CSlideId":"","ControlKey":"ab640e69-acb2-44b3-b2c7-14ac4075cde6","ControlNumber":"10773","DisclosureBlock":"&nbsp;<b>M. Serresi, <\/b> None..<br><b>S. Kertalli, <\/b> None..<br><b>Y. Dramaretska, <\/b> None..<br><b>M. J. Schmitt, <\/b> None..<br><b>H. Naumann, <\/b> None..<br><b>M. Zschummel, <\/b> None..<br><b>G. Gargiulo, <\/b> None.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10701","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"7","PosterboardNumber":"7","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB212","PresenterBiography":null,"PresenterDisplayName":"Gaetano Gargiulo, PhD","PresenterKey":"339ced4b-55c5-4032-9f61-cb82e848238c","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB212. Transcriptional dosage of oncogenic KRAS drives lung adenocarcinoma cell states, progression and metastasis","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Transcriptional dosage of oncogenic KRAS drives lung adenocarcinoma cell states, progression and metastasis","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB04-09 Metastasis suppressor genes,,"},{"Key":"Keywords","Value":"Metastasis,Osteoclast,Estrogen receptor,Ras,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>Z. Zhao<\/b><sup>1<\/sup>, Z.-Y. Zheng<sup>1<\/sup>, J. Lei<sup>1<\/sup>, M. J. Baik<sup>1<\/sup>, Y.-H. Wu<sup>1<\/sup>, J. Wang<sup>1<\/sup>, I. Bado<sup>2<\/sup>, M. Anurag<sup>1<\/sup>, B. Zhang<sup>1<\/sup>, X. Zhang<sup>1<\/sup>, E. Chang<sup>1<\/sup>; <br\/><sup>1<\/sup>Baylor College of Medicine, Houston, TX, <sup>2<\/sup>Mount Sinai, New York, NY","CSlideId":"","ControlKey":"8b656745-8a62-4646-82e2-b179e1b90e57","ControlNumber":"9941","DisclosureBlock":"&nbsp;<b>Z. Zhao, <\/b> None..<br><b>Z. Zheng, <\/b> None..<br><b>J. Lei, <\/b> None..<br><b>M. J. Baik, <\/b> None..<br><b>Y. Wu, <\/b> None..<br><b>J. Wang, <\/b> None..<br><b>I. Bado, <\/b> None..<br><b>M. Anurag, <\/b> None..<br><b>B. Zhang, <\/b> None..<br><b>X. Zhang, <\/b> None..<br><b>E. Chang, <\/b> None.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10702","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"8","PosterboardNumber":"8","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB213","PresenterBiography":null,"PresenterDisplayName":"Zifan Zhao, BS","PresenterKey":"b405ffb9-73d1-40c0-84b8-dc25b4a0b1d7","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB213. NF1 loss promotes bone metastasis in estrogen receptor positive breast cancer","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"NF1 loss promotes bone metastasis in estrogen receptor positive breast cancer","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB05-01 3-D and tissue recombinant models,,"},{"Key":"Keywords","Value":"Spheroids,Screening,DNA polymerase,Combination studies,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>B. A. Teicher<\/b><sup>1<\/sup>, T. S. Dexheimer<sup>2<\/sup>, T. Silvers<sup>2<\/sup>, N. P. Coussens<sup>2<\/sup>, J. Eder<sup>3<\/sup>, J. H. Doroshow<sup>1<\/sup>; <br\/><sup>1<\/sup>National Cancer Institute, Bethesda, MD, <sup>2<\/sup>Frederick National Laboratory for Cancer Research, Frederick, MD, <sup>3<\/sup>Yale School of Medicine, New Haven, CT","CSlideId":"","ControlKey":"89374443-8608-4e60-9784-b7dfd7a75727","ControlNumber":"9533","DisclosureBlock":"&nbsp;<b>B. A. Teicher, <\/b> None..<br><b>T. S. Dexheimer, <\/b> None..<br><b>T. Silvers, <\/b> None..<br><b>N. P. Coussens, <\/b> None..<br><b>J. Eder, <\/b> None..<br><b>J. H. Doroshow, <\/b> None.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10704","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"9","PosterboardNumber":"10","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB215","PresenterBiography":null,"PresenterDisplayName":"Beverly Teicher, PhD","PresenterKey":"4770ce86-d1f8-40da-9367-3cd8645b52e4","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB215. Polymerase &#952; (POL&#952;) inhibitors (novobiocin, ART-558, RP6685) were tested with 22 approved and investigational agents in multi-cell type spheroids of genetically selected patient-derived human tumor cell lines","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Polymerase &#952; (POL&#952;) inhibitors (novobiocin, ART-558, RP6685) were tested with 22 approved and investigational agents in multi-cell type spheroids of genetically selected patient-derived human tumor cell lines","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB05-07 Organoids,,"},{"Key":"Keywords","Value":"Microfluidics,Ovarian cancer,Organoids,Precision medicine,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>E. Cavarzerani<\/b><sup>1<\/sup>, G. Saorin<sup>1<\/sup>, M. Mauceri<sup>1<\/sup>, I. Caligiuri<sup>2<\/sup>, M. Bartoletti<sup>2<\/sup>, V. Canzonieri<sup>2<\/sup>, F. Rizzolio<sup>1<\/sup>; <br\/><sup>1<\/sup>Ca' Foscari University of Venice, Venezia, Italy, <sup>2<\/sup>Centro di Riferimento Oncologico di Aviano, Aviano, Italy","CSlideId":"","ControlKey":"da1b2684-7e1d-41ff-8f5d-8b0518f22125","ControlNumber":"10552","DisclosureBlock":"&nbsp;<b>E. Cavarzerani, <\/b> None..<br><b>G. Saorin, <\/b> None..<br><b>M. Mauceri, <\/b> None..<br><b>I. Caligiuri, <\/b> None..<br><b>M. Bartoletti, <\/b> None..<br><b>V. Canzonieri, <\/b> None..<br><b>F. Rizzolio, <\/b> None.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10705","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"10","PosterboardNumber":"11","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB216","PresenterBiography":null,"PresenterDisplayName":"Enrico Cavarzerani, MD","PresenterKey":"cf5d53e8-61a1-4bee-951d-e5a2767d1336","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB216. Static and microfluidic platforms for novel therapeutic testing in high-grade serous ovarian cancer","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Static and microfluidic platforms for novel therapeutic testing in high-grade serous ovarian cancer","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB05-07 Organoids,,"},{"Key":"Keywords","Value":"Prostate cancer,Organoids,Resistance,Heterogeneity,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>J. Lu<\/b>, M. M. Shen; <br\/>Columbia University Irving Medical Center, New York, NY","CSlideId":"","ControlKey":"5b9d83b2-c908-469c-b63b-84e373788292","ControlNumber":"10880","DisclosureBlock":"&nbsp;<b>J. Lu, <\/b> None..<br><b>M. M. Shen, <\/b> None.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10706","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"11","PosterboardNumber":"12","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB217","PresenterBiography":null,"PresenterDisplayName":"Jinqiu Lu, PhD","PresenterKey":"afd12b16-966a-4255-a361-ccbd4dc41ce6","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB217. Novel organoid models of lineage plasticity in castration resistant prostate cancer","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Novel organoid models of lineage plasticity in castration resistant prostate cancer","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB05-07 Organoids,,"},{"Key":"Keywords","Value":"Antibody,Spheroids,Preclinical testing,Targeted therapy,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"A. Aref<sup>1<\/sup>, A. Martin<sup>1<\/sup>, H. Aboulkheyr Es<sup>2<\/sup>, P. Krzesaj<sup>2<\/sup>, V. Adler<sup>2<\/sup>, K. Khardenavis<sup>1<\/sup>, E. Sarafraz-Yazdi<sup>2<\/sup>, <b>M. A. Perricone<\/b><sup>1<\/sup>; <br\/><sup>1<\/sup>Xsphera Biosciences, Inc., Boston, MA, <sup>2<\/sup>NomoCan Pharmaceuticals, New York, NY","CSlideId":"","ControlKey":"302a5a3a-9da6-4f59-a074-6b046c54be99","ControlNumber":"10840","DisclosureBlock":"<b>&nbsp;A. Aref, <\/b> <br><b>xsphera Biosciences Inc.<\/b> Employment, Stock. <br><b>NomoCan Pharmaceuticals<\/b> Grant\/Contract. <br><b>A. Martin, <\/b> <br><b>Xsphera Biosciences Inc.<\/b> Employment, Stock Option. <br><b>NomoCan Pharmaceuticals<\/b> Grant\/Contract. <br><b>H. Aboulkheyr Es, <\/b> <br><b>NomoCan Pharmaceuticals<\/b> Employment. <br><b>P. Krzesaj, <\/b> <br><b>NomoCan Pharmaceuticals<\/b> Employment. <br><b>V. Adler, <\/b> <br><b>NomoCan Pharmaceuticals<\/b> Employment. <br><b>K. Khardenavis, <\/b> <br><b>Xsphera Biosciences Inc.<\/b> Employment. <br><b>E. Sarafraz-Yazdi, <\/b> <br><b>NomoCan Pharmaceuticals<\/b> Employment. <br><b>M. A. Perricone, <\/b> <br><b>Xsphera Biosciences Inc.<\/b> Employment, Stock. <br><b>NomoCan Pharmaceuticals<\/b> Grant\/Contract.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10707","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"12","PosterboardNumber":"13","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB218","PresenterBiography":null,"PresenterDisplayName":"Michael Perricone, PhD","PresenterKey":"f8c7e711-81b7-49cf-9b2d-a244d853b877","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB218. Advanced ex vivo platform for drug response analysis: Evaluating the potent effects of NMC-521 mAb on mouse-and patient-derived organotypic tumor spheroids","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Advanced ex vivo platform for drug response analysis: Evaluating the potent effects of NMC-521 mAb on mouse-and patient-derived organotypic tumor spheroids","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB05-07 Organoids,,"},{"Key":"Keywords","Value":"Gastrointestinal cancers: stomach,Gastrointestinal cancers: colorectal,DCLK1,Patient-derived xenograft (PDX) models,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>D. Qu<\/b><sup>1<\/sup>, J. Shi<sup>2<\/sup>, Z. Cao<sup>2<\/sup>, E. BAnnerman-Menson<sup>3<\/sup>, N. Weygant<sup>4<\/sup>, C. Houchen<sup>1<\/sup>; <br\/><sup>1<\/sup>University of Oklahoma Health Sciences Center, Oklahoma City, OK, <sup>2<\/sup>Fujian University of Tranditional Chinese Medicine, Fuzhou, China, <sup>3<\/sup>COARE Holding Inc., Oklahoma City, OK, <sup>4<\/sup>Fujian University of Traditional Chinese Medicine, Fuzhou, China","CSlideId":"","ControlKey":"efcf8674-f844-47fd-bb25-b9ca2d53a125","ControlNumber":"10295","DisclosureBlock":"<b>&nbsp;D. Qu, <\/b> <br><b>COARE Holding Inc.<\/b> Grant\/Contract, Other Intellectual Property.<br><b>J. Shi, <\/b> None..<br><b>Z. Cao, <\/b> None..<br><b>E. BAnnerman-Menson, <\/b> None..<br><b>N. Weygant, <\/b> None.&nbsp;<br><b>C. Houchen, <\/b> <br><b>COARE Holding Inc.<\/b> Founder.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10708","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"13","PosterboardNumber":"14","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB219","PresenterBiography":null,"PresenterDisplayName":"Dongfeng Qu, PhD","PresenterKey":"7704b713-1151-48e5-9e4e-0cbd06ee4ee5","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB219. DCLK1 is a novel therapeutic target for gastric and colorectal cancers as demonstrated by patient-derived organoids assays","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"DCLK1 is a novel therapeutic target for gastric and colorectal cancers as demonstrated by patient-derived organoids assays","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB05-08 Other animal and cell models of cancer,,"},{"Key":"Keywords","Value":"KRAS,Cancer therapy,Inhibitors,H-Ras,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>J. Timar<\/b><sup>1<\/sup>, M. Baranyi<sup>1<\/sup>, E. Molnar<sup>1<\/sup>, I. Randelovic<sup>2<\/sup>, M. Cserepes<sup>2<\/sup>, J. Tovari<sup>3<\/sup>, B. Hegedus<sup>4<\/sup>; <br\/><sup>1<\/sup>Semmelweis University, Department of Pathology, Budapest, Hungary, <sup>2<\/sup>Kinetolab Ltd, Budapest, Hungary, <sup>3<\/sup>National Institute of Oncology, Budapest, Hungary, <sup>4<\/sup>University Duisburg-Essen, Essen, Germany","CSlideId":"","ControlKey":"5c1c81d2-8823-4f10-a1e3-d5ec3dc789a5","ControlNumber":"10550","DisclosureBlock":"&nbsp;<b>J. Timar, <\/b> None.&nbsp;<br><b>M. Baranyi, <\/b> <br><b>KInetolab Ltd<\/b> Employment.<br><b>E. Molnar, <\/b> None.&nbsp;<br><b>I. Randelovic, <\/b> <br><b>Kinetolab Ltd<\/b> Employment. <br><b>M. Cserepes, <\/b> <br><b>Kinetolab ltd<\/b> Employment.<br><b>J. Tovari, <\/b> None..<br><b>B. Hegedus, <\/b> None.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10709","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"14","PosterboardNumber":"15","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB220","PresenterBiography":null,"PresenterDisplayName":"Jozsef Timar","PresenterKey":"81b7ff28-bcfd-4f68-899e-0b1307f86d9c","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB220. Farnesyltransferase inhibitors show synergistic anticancer effects in combination with novel KRAS G12C inhibitors","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Farnesyltransferase inhibitors show synergistic anticancer effects in combination with novel KRAS G12C inhibitors","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB06-05 Other,,"},{"Key":"Keywords","Value":"Neuroblastoma,Therapeutic target,Peptides,Pediatric cancers,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"D. Somasundaram<sup>1<\/sup>, P. Subramanian<sup>1<\/sup>, S. Mohanvelu<sup>1<\/sup>, S. Aravindan<sup>2<\/sup>, <b>N. Aravindan<\/b><sup>1<\/sup>; <br\/><sup>1<\/sup>Oklahoma State University, Stillwater, OK, <sup>2<\/sup>Stephenson Cancer Center, Oklahoma City, OK","CSlideId":"","ControlKey":"4eeaad61-b3e6-4f05-8963-747ad1a41eb8","ControlNumber":"10299","DisclosureBlock":"&nbsp;<b>D. Somasundaram, <\/b> None..<br><b>P. Subramanian, <\/b> None..<br><b>S. Mohanvelu, <\/b> None..<br><b>S. Aravindan, <\/b> None..<br><b>N. Aravindan, <\/b> None.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10710","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"15","PosterboardNumber":"16","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB221","PresenterBiography":null,"PresenterDisplayName":"Natarajan Aravindan, PhD","PresenterKey":"c64eae8f-b870-4f80-b014-cc1758a5144c","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB221. Novel molecular targeted tumor targeted oncolytic peptide for the treatment of therapy resistant progressive neuroblastoma","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Novel molecular targeted tumor targeted oncolytic peptide for the treatment of therapy resistant progressive neuroblastoma","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB07-07 Radiobiology research,,"},{"Key":"Keywords","Value":"Radiosensitization,Radioligand therapy,DNA damage response,PSMA,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"M. Ranzani *<sup>1<\/sup>, <b>S. Hindupur *<\/b><sup>2<\/sup>, A. Cicconi<sup>1<\/sup>, G. Sastre-Moreno<sup>2<\/sup>, A. Kristian<sup>2<\/sup>, B. Schacher Engstler<sup>2<\/sup>, B. Pinch<sup>3<\/sup>, C. Hartnagel<sup>2<\/sup>, D. Gorses<sup>2<\/sup>, E. Simon<sup>2<\/sup>, E. Mandon<sup>2<\/sup>, E. Schramm<sup>2<\/sup>, F. Schaeffer<sup>2<\/sup>, J. Reber<sup>2<\/sup>, L. Barys<sup>2<\/sup>, L. Deberle<sup>2<\/sup>, M. Walter<sup>2<\/sup>, R. Bessey<sup>2<\/sup>, R. Destefani<sup>2<\/sup>, X. Miot<sup>2<\/sup>, E. Elinati<sup>1<\/sup>, N. Shao<sup>1<\/sup>, M. Boursier<sup>1<\/sup>, J. Barlow<sup>1<\/sup>, A. Thapa<sup>1<\/sup>, A. Galbiati<sup>1<\/sup>, D. Grande<sup>1<\/sup>, E. Rajendra<sup>1<\/sup>, N. Martin<sup>1<\/sup>, G. Smith<sup>1<\/sup>, T. Schmelzle<sup>2<\/sup>, M. Reschke<sup>2<\/sup>, H. Robinson #<sup>1<\/sup>, M. Cortes-Cros #<sup>2<\/sup>; <br\/><sup>1<\/sup>Artios Pharma Limited, Cambridge, United Kingdom, <sup>2<\/sup>Novartis Biomedical Research, Basel, Switzerland, <sup>3<\/sup>Novartis Biomedical Research, Cambridge, MA","CSlideId":"","ControlKey":"19475f5d-ee98-4b25-b0cf-a92315d538da","ControlNumber":"9688","DisclosureBlock":"<b>&nbsp;M. Ranzani *, <\/b> <br><b>Artios Pharma Limited<\/b> Employment, Stock Option. <br><b>S. Hindupur *, <\/b> <br><b>Novartis Pharma AG<\/b> Employment, Stock. <br><b>A. Cicconi, <\/b> <br><b>Artios Pharma Limited<\/b> Employment, Stock Option. <br><b>G. Sastre-Moreno, <\/b> <br><b>Novartis Pharma AG<\/b> Employment. <br><b>A. Kristian, <\/b> <br><b>Novartis Pharma AG<\/b> Employment, Stock. <br><b>B. Schacher Engstler, <\/b> <br><b>Novartis Pharma AG<\/b> Employment, Stock. <br><b>B. Pinch, <\/b> <br><b>Novartis Pharma<\/b> Employment, Stock. <br><b>Dana Farber Cancer Institute<\/b> Patent. <br><b>C. Hartnagel, <\/b> <br><b>Novartis Pharma AG<\/b> Employment. <br><b>D. Gorses, <\/b> <br><b>Novartis Pharma AG<\/b> Employment, Stock. <br><b>E. Simon, <\/b> <br><b>Novartis Pharma AG<\/b> Employment, Stock. <br><b>E. Mandon, <\/b> <br><b>Novartis Pharma AG<\/b> Employment, Stock. <br><b>E. Schramm, <\/b> <br><b>Novartis Pharma AG<\/b> Employment, Stock. <br><b>F. Schaeffer, <\/b> <br><b>Novartis Pharma AG<\/b> Employment, Stock. <br><b>J. Reber, <\/b> <br><b>Novartis Pharma AG<\/b> Employment. <br><b>L. Barys, <\/b> <br><b>Novartis Pharma AG<\/b> Employment, Stock. <br><b>L. Deberle, <\/b> <br><b>Novartis Pharma AG<\/b> Employment, Stock. <br><b>Paul Scherrer Institute<\/b> Patent. <br><b>ITM Isotope Technologies Munich SE<\/b> Patent. <br><b>M. Walter, <\/b> <br><b>Novartis Pharma AG<\/b> Employment, Stock. <br><b>R. Bessey, <\/b> <br><b>Novartis Pharma AG<\/b> Employment, Stock. <br><b>R. Destefani, <\/b> <br><b>Novartis Pharma AG<\/b> Employment, Stock. <br><b>X. Miot, <\/b> <br><b>Novartis Pharma AG<\/b> Employment, Stock. <br><b>E. Elinati, <\/b> <br><b>Artios Pharma Limited<\/b> Employment, Stock Option. <br><b>N. Shao, <\/b> <br><b>Artios Pharma Limited<\/b> Employment, Stock Option. <br><b>M. Boursier, <\/b> <br><b>Artios Pharma Limited<\/b> Stock Option. <br><b>Pierre Fabre<\/b> Employment. <br><b>J. Barlow, <\/b> <br><b>Artios Pharma Limited<\/b> Employment, Stock Option. <br><b>A. Thapa, <\/b> <br><b>Artios Pharma Limited<\/b> Employment. <br><b>BenevolentAI<\/b> Stock Option. <br><b>A. Galbiati, <\/b> <br><b>Artios Pharma Limited<\/b> Employment, Stock Option. <br><b>D. Grande, <\/b> <br><b>Artios Pharma Limited<\/b> Employment. <br><b>E. Rajendra, <\/b> <br><b>Artios Pharma Limited<\/b> Employment, Stock Option, Patent. <br><b>N. Martin, <\/b> <br><b>Artios Pharma Limited<\/b> Employment, Stock Option. <br><b>G. Smith, <\/b> <br><b>Artios Pharma Limited<\/b> Employment, Stock Option, Patent. <br><b>Astra Zeneca<\/b> Stock. <br><b>T. Schmelzle, <\/b> <br><b>Novartis Pharma AG<\/b> Employment, Stock, Stock Option, Patent. <br><b>M. Reschke, <\/b> <br><b>Novartis Pharma AG<\/b> Employment, Stock, Stock Option, Patent. <br><b>H. Robinson #, <\/b> <br><b>Artios Pharma Limited<\/b> Employment, Stock Option. <br><b>M. Cortes-Cros #, <\/b> <br><b>Novartis Pharma AG<\/b> Employment, Stock, Patent.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10711","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"16","PosterboardNumber":"17","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB222","PresenterBiography":null,"PresenterDisplayName":"Sravanth Hindupur, PhD","PresenterKey":"88be9b84-d036-4e22-90d8-fdf838c7c8f7","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB222. Elucidating the cellular responses and mechanism of action of <sup>177<\/sup>Lu-based radioligand therapy","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Elucidating the cellular responses and mechanism of action of <sup>177<\/sup>Lu-based radioligand therapy","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB08-01 Adult stem cells,,"},{"Key":"Keywords","Value":"Differentiation,Stemness,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>Q. Vallmajó Martín<\/b><sup>1<\/sup>, N. K. Lytle<sup>2<\/sup>, D. Murali<sup>3<\/sup>, S. Srinivasan<sup>3<\/sup>, Z. Ma<sup>1<\/sup>, K. Mukund<sup>3<\/sup>, C. Dravis<sup>1<\/sup>, L. Zamora<sup>1<\/sup>, A. Peterson<sup>1<\/sup>, G. Khramtsova<sup>4<\/sup>, F. Olopade<sup>4<\/sup>, S. Subramaniam<sup>3<\/sup>, G. M. Wahl<sup>1<\/sup>; <br\/><sup>1<\/sup>Salk Institute For Biological Studies, San Diego, CA, <sup>2<\/sup>Medical College of Wisconsin, Milwaukee, WI, <sup>3<\/sup>University of California, San Diego, San Diego, CA, <sup>4<\/sup>The University of Chicago, Chicago, IL","CSlideId":"","ControlKey":"dc375b8c-05bd-4489-9768-856951fd45e0","ControlNumber":"9681","DisclosureBlock":"&nbsp;<b>Q. Vallmajó Martín, <\/b> None..<br><b>N. K. Lytle, <\/b> None..<br><b>D. Murali, <\/b> None..<br><b>S. Srinivasan, <\/b> None..<br><b>Z. Ma, <\/b> None..<br><b>K. Mukund, <\/b> None..<br><b>C. Dravis, <\/b> None..<br><b>L. Zamora, <\/b> None..<br><b>A. Peterson, <\/b> None..<br><b>G. Khramtsova, <\/b> None..<br><b>F. Olopade, <\/b> None..<br><b>S. Subramaniam, <\/b> None..<br><b>G. M. Wahl, <\/b> None.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10712","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"17","PosterboardNumber":"18","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB223","PresenterBiography":null,"PresenterDisplayName":"Queralt Vallmajó Martín, PhD,BS,MS","PresenterKey":"4efd579a-1a94-4234-8b1b-194516a9a593","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB223. The molecular landscape of injury-induced mammary epithelial cell fate switching","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"The molecular landscape of injury-induced mammary epithelial cell fate switching","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB08-02 Cancer stem cells,,"},{"Key":"Keywords","Value":"Cancer stem cells,Molecular markers,Malignant progression,Breast cancer,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>E. B. Berens<\/b>, S. Khou, E. Huang, A. Hoffman, B. Johnson, Z. Werb, L. M. Heiser, L. M. Coussens; <br\/>OHSU, Portland, OR","CSlideId":"","ControlKey":"96e88b48-36ae-4670-8132-55b66fe58634","ControlNumber":"10733","DisclosureBlock":"&nbsp;<b>E. B. Berens, <\/b> None..<br><b>S. Khou, <\/b> None..<br><b>E. Huang, <\/b> None..<br><b>A. Hoffman, <\/b> None..<br><b>B. Johnson, <\/b> None..<br><b>Z. Werb, <\/b> None..<br><b>L. M. Heiser, <\/b> None..<br><b>L. M. Coussens, <\/b> None.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10713","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"18","PosterboardNumber":"19","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB224","PresenterBiography":null,"PresenterDisplayName":"Eric Berens, PhD","PresenterKey":"f09c2029-bb27-4d17-9150-02e7f774bf75","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB224. Neoplastic immune mimicry potentiates breast cancer progression","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Neoplastic immune mimicry potentiates breast cancer progression","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB08-02 Cancer stem cells,,"},{"Key":"Keywords","Value":"Cancer stem cells,Metastasis,Breast cancer,Epithelial-mesenchymal transition (EMT),"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>Joanna Joyce Maddela<\/b><sup>1<\/sup>, Maria Castaneda<sup>2<\/sup>, Petra den Hollander<sup>1<\/sup>, Nick Kuburich<sup>1<\/sup>, Sendurai Mani<sup>1<\/sup><br><br\/><sup>1<\/sup>Legorreta Cancer Center at Brown University, Providence, RI,<sup>2<\/sup>The University of Texas MD Anderson Cancer Center, Houston, TX","CSlideId":"","ControlKey":"61d6a90e-90a4-458a-aae2-488ff42a7f7d","ControlNumber":"10467","DisclosureBlock":"&nbsp;<b>J. J. Maddela, <\/b> None..<br><b>M. Castaneda, <\/b> None..<br><b>P. den Hollander, <\/b> None..<br><b>N. Kuburich, <\/b> None..<br><b>S. Mani, <\/b> None.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10714","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"19","PosterboardNumber":"20","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB225","PresenterBiography":null,"PresenterDisplayName":"Joanna Maddela, BS","PresenterKey":"0f1065de-f67b-4388-9c62-4967a332b440","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB225. Regulation of breast cancer stem cell identity by PLK1 and FOXC2","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Regulation of breast cancer stem cell identity by PLK1 and FOXC2","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB10-01 Causes and consequences of tumor heterogeneity,,"},{"Key":"Keywords","Value":"Lung adenocarcinoma,Tumor evolution,LINE-1 Retrotransposition,Mutational Signature,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>T. Zhang<\/b><sup>1<\/sup>, W. Zhao<sup>1<\/sup>, C. Wirth<sup>2<\/sup>, M. Díaz-Gay<sup>3<\/sup>, J. Yin<sup>1<\/sup>, P. H. Hoang<sup>1<\/sup>, J. Sang<sup>1<\/sup>, J. McElderry<sup>1<\/sup>, A. Klein<sup>1<\/sup>, A. Khandekar<sup>1<\/sup>, C. Hartman<sup>1<\/sup>, J. Rosenbaum<sup>1<\/sup>, F. Colon-Matos<sup>1<\/sup>, K. M. Jones<sup>1<\/sup>, N. E. Caporaso<sup>1<\/sup>, R. Homer<sup>4<\/sup>, A. C. Pesatori<sup>5<\/sup>, D. Consonni<sup>6<\/sup>, L. Yang<sup>7<\/sup>, B. Zhu<sup>1<\/sup>, J. Shi<sup>1<\/sup>, K. Brown<sup>1<\/sup>, N. Rothman<sup>1<\/sup>, S. J. Chanock<sup>1<\/sup>, L. B. Alexandrov<sup>3<\/sup>, J. Choi<sup>1<\/sup>, M. Cardelli<sup>8<\/sup>, Q. Lan<sup>1<\/sup>, M. A. Nowak<sup>9<\/sup>, D. C. Wedge<sup>2<\/sup>, M. T. Landi<sup>1<\/sup>; <br\/><sup>1<\/sup>National Institutes of Health (NIH), Rockville, MD, <sup>2<\/sup>The University of Manchester, Manchester, United Kingdom, <sup>3<\/sup>University of California San Diego, La Jolla, CA, <sup>4<\/sup>Yale School of Medicine, New Haven, CT, <sup>5<\/sup>University of Milan, Milan, Italy, <sup>6<\/sup>Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy, <sup>7<\/sup>The University of Chicago, Chicago, IL, <sup>8<\/sup>IRCCS INRCA, Ancona, Italy, <sup>9<\/sup>Harvard University, Cambridge, MA","CSlideId":"","ControlKey":"c9ce6ce2-deac-49ed-8566-8c7363349f19","ControlNumber":"10685","DisclosureBlock":"&nbsp;<b>T. Zhang, <\/b> None..<br><b>W. Zhao, <\/b> None..<br><b>C. Wirth, <\/b> None..<br><b>M. Díaz-Gay, <\/b> None..<br><b>J. Yin, <\/b> None..<br><b>P. H. Hoang, <\/b> None..<br><b>J. Sang, <\/b> None..<br><b>J. McElderry, <\/b> None..<br><b>A. Klein, <\/b> None..<br><b>A. Khandekar, <\/b> None..<br><b>C. Hartman, <\/b> None..<br><b>J. Rosenbaum, <\/b> None..<br><b>F. Colon-Matos, <\/b> None..<br><b>K. M. Jones, <\/b> None..<br><b>N. E. Caporaso, <\/b> None..<br><b>R. Homer, <\/b> None..<br><b>A. C. Pesatori, <\/b> None..<br><b>D. Consonni, <\/b> None..<br><b>L. Yang, <\/b> None..<br><b>B. Zhu, <\/b> None..<br><b>J. Shi, <\/b> None..<br><b>K. Brown, <\/b> None..<br><b>N. Rothman, <\/b> None..<br><b>S. J. Chanock, <\/b> None.&nbsp;<br><b>L. B. Alexandrov, <\/b> <br><b>io9, LLC<\/b> LBA is a compensated consultant and has an equity interest in io9, LLC.<br><b>J. Choi, <\/b> None..<br><b>M. Cardelli, <\/b> None..<br><b>Q. Lan, <\/b> None..<br><b>M. A. Nowak, <\/b> None..<br><b>D. C. Wedge, <\/b> None..<br><b>M. T. Landi, <\/b> None.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10715","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"20","PosterboardNumber":"21","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB226","PresenterBiography":null,"PresenterDisplayName":"Tongwu Zhang, PhD","PresenterKey":"a67b6d48-8f6c-45f1-9646-58fe59566818","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB226. Deciphering lung adenocarcinoma evolution and the role of LINE-1 retrotransposition","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Deciphering lung adenocarcinoma evolution and the role of LINE-1 retrotransposition","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB10-01 Causes and consequences of tumor heterogeneity,,"},{"Key":"Keywords","Value":"Aging,Gene expression analysis,Single cell,Heterogeneity,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"L. Naddaf<sup>1<\/sup>, M. De Dominici<sup>2<\/sup>, X. Chen<sup>1<\/sup>, T. Roeder<sup>3<\/sup>, H. Oguro<sup>3<\/sup>, S. Karmakar<sup>1<\/sup>, E. Pietras<sup>2<\/sup>, J. DeGregori<sup>2<\/sup>, <b>S. Li<\/b><sup>4<\/sup>; <br\/><sup>1<\/sup>The Jackson Laboratory for Genomic Medicine, Farmington, CT, <sup>2<\/sup>University of Colorado Anschutz Medical Campus, Aurora, CO, <sup>3<\/sup>University of Connecticut Health Center, Farmington, CT, <sup>4<\/sup>The Jackson Laboratory for Genomic Medicine, West Hartford, CT","CSlideId":"","ControlKey":"b2b9bc75-2bb6-4909-9861-f458dd041fa5","ControlNumber":"10708","DisclosureBlock":"&nbsp;<b>L. Naddaf, <\/b> None..<br><b>M. De Dominici, <\/b> None.&nbsp;<br><b>X. Chen, <\/b> <br><b>Merck & Co.<\/b> Employment.<br><b>T. Roeder, <\/b> None..<br><b>H. Oguro, <\/b> None..<br><b>S. Karmakar, <\/b> None..<br><b>E. Pietras, <\/b> None..<br><b>J. DeGregori, <\/b> None..<br><b>S. Li, <\/b> None.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10716","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"21","PosterboardNumber":"22","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB227","PresenterBiography":null,"PresenterDisplayName":"Sheng Li, PhD","PresenterKey":"445c16d0-2ee9-4b07-b812-f570329bfa31","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB227. Accelerated intra-clonal transcriptomic diversification of hematopoietic stem cells during aging fuels leukemia evolution","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Accelerated intra-clonal transcriptomic diversification of hematopoietic stem cells during aging fuels leukemia evolution","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++TB10-04 Other,,"},{"Key":"Keywords","Value":"Tumor evolution,Lung cancer,Copy number,Genomic instability,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"C. Wirth<sup>1<\/sup>, T. Zhang<sup>2<\/sup>, W. Zhao<sup>2<\/sup>, P. Hoang<sup>2<\/sup>, J. Sang<sup>2<\/sup>, N. Rothman<sup>2<\/sup>, M. Díaz-Gay<sup>3<\/sup>, R. Teslo<sup>4<\/sup>, N. Ansari-Pour<sup>5<\/sup>, M. Ní Leathlobhair<sup>6<\/sup>, I. Peneva<sup>5<\/sup>, W. Eagles<sup>4<\/sup>, L. Yang<sup>7<\/sup>, L. Alexandrov<sup>3<\/sup>, <b>D. C. Wedge<\/b><sup>1<\/sup>, M. Landi<sup>2<\/sup>; <br\/><sup>1<\/sup>University of Manchester, Manchester, United Kingdom, <sup>2<\/sup>National Cancer Institute, Bethesda, MD, <sup>3<\/sup>University of California San Diego, San Diego, CA, <sup>4<\/sup>Wellcome Sanger Institute, Cambridge, United Kingdom, <sup>5<\/sup>University of Oxford, Oxford, United Kingdom, <sup>6<\/sup>Trinity College Dublin, Dublin, Ireland, <sup>7<\/sup>University of Chicago, Chicago, IL","CSlideId":"","ControlKey":"255e5421-e1f2-45b1-a14a-0bf310e52a09","ControlNumber":"10667","DisclosureBlock":"&nbsp;<b>C. Wirth, <\/b> None..<br><b>T. Zhang, <\/b> None..<br><b>W. Zhao, <\/b> None..<br><b>P. Hoang, <\/b> None..<br><b>J. Sang, <\/b> None..<br><b>N. Rothman, <\/b> None..<br><b>M. Díaz-Gay, <\/b> None..<br><b>R. Teslo, <\/b> None..<br><b>N. Ansari-Pour, <\/b> None..<br><b>M. Ní Leathlobhair, <\/b> None..<br><b>I. Peneva, <\/b> None..<br><b>W. Eagles, <\/b> None..<br><b>L. Yang, <\/b> None..<br><b>L. Alexandrov, <\/b> None..<br><b>D. C. Wedge, <\/b> None..<br><b>M. Landi, <\/b> None.","End":"4\/8\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10717","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"22","PosterboardNumber":"23","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB228","PresenterBiography":null,"PresenterDisplayName":"David Wedge, PhD","PresenterKey":"2a76c521-dda2-4a84-93d3-b3b5756dc2c6","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB228. Evolutionary trajectories of lung cancer in never smokers","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  1:30PM","SessionId":"607","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Tumor Biology 1","ShowChatLink":"false","Start":"4\/8\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Evolutionary trajectories of lung cancer in never smokers","Topics":null,"cSlideId":""}]